Aiims

New Delhi (CNN) — A familiar scene is taking place in northern India. Vast fields burn, flames engulfing bare stalks of already-harvested crops. Billowing smoke travels across state borders. In towns and cities, the air is thick with yellow haze. Stubble burning, the practice of intentionally setting fire to cultivated...Coronavirus Disease 2019North IndiaNew DelhiSmogUnited StatesCOVID-19 PandemicPunjab StateAir Pollution DeathsEnvironmental PollutionBeijing PollutionWinter CropsUniversity Of ChicagoAIIMSCNNWorld Health OrganizationRandeep GuleriaRead Full Story

New Delhi (CNN) — Health officials in India have found excessive amounts of lead and nickel in blood samples taken from patients who have been hospitalized in Andhra Pradesh, officials investigating the cases said Tuesday. More than 500 people have been hospitalized for an unidentified illness in southeastern India, according...Read Full Story NickelAndhra PradeshNew DelhiPatient InfectionsSeizuresHealth OfficialsDepartment Of HealthCNNEluruAIIMSIICTPublic HealthPatient Blood SamplesExcessive AmountsSymptomsJagan

A vaccine for COVID-19 is likely to be in the market soon though it may be some time before the general population has access to it. We have recently seen many vaccine developers announcing the efficacy rate of their candidate on the basis of final stage clinical trials. Many companies are also coming forth with possible costs of the vaccines. Against this backdrop, the phase-III human trials of India’s indigenous COVID-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday. M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as part of the clinical trials.Read Full Story Covid-19Public HealthCoronavirus Disease 2019Time TrialsHuman TrialsClinical ResearchAIIMSNeurosciences CentreICMRBharat Biotech 'sVeroParticipating VolunteersNIVIANSPhase-3 Trials

Bhubaneswar: Chief Minister Naveen Patnaik on Sunday thanked the Indian scientists for coming out with the vaccines against COVID-19. Taking to his Twitter handle, the chief minister said it is a matter of great pride that two Made in India vaccines have received approval by the panel of experts for emergency use.Read Full StoryMade In IndiaCovid-19Public HealthChief MinisterOdisha CMIndianDCGIAIIMSBharat Biotech 'sTwitterIndia VaccinesSerum Institute VaccineScientistsBhubaneswarEmergencyNaveen PatnaikRandeep Guleria

New Delhi: A total of 3,81,305 people have received the first dose of COVID-19 vaccine in the country so far. Of these, 580 post-vaccination adverse events have been reported, the Health Ministry said on Monday. A total of 1,48,266 beneficiaries received the jab till 5 pm on Monday. “A total...Read Full StoryLakhNew DelhiIndiaPublic HealthHealth ReportsAdverse EventsThe Health MinistryMax HospitalAIIMS RishikeshAEFIVaccinationCOVID-19 VaccineKarnatakaChhattisgarhProvisional Reports

It was a muted finale to a saga that has rivalled the wildest movie storylines. On Wednesday, the Bollywood star Rhea Chakraborty stepped out of the Byculla women’s prison in Mumbai, released on bail after 28 days in j

A five-year-old Indian boy, who was separated from his conjoined twin in 2017, has died. Jaga and Kalia, who were conjoined at the top of their heads, underwent several major surgeries when they were two years old. Kalia died on Wednesday after falling ill with sepsis, doctors said. They were...Read Full Story SepsisOdishaOrissaConjoined TwinDelhiMedical DoctorsThe BrainIndianThe Hindustan TimesAiimsCaptionThe TwinsShared Blood VesselsBrain TissuesKaliaDr Bhubanananda Maharana

Anaemia is medically defined as a condition where there is a decrease in the amount of hemoglobin or a drop in the number of red blood cells in the blood. This may be due to several reasons with the most common one being a deficiency of iron, which is necessary to produce hemoglobin. Such anaemia is called iron deficiency or hypochromic or microcytic anaemia and is typical in pregnant women, growing children, and women with excessive bleeding during menstruation. But apart from that, other types of anaemia are caused due to a deficiency of vitamin B-12, destruction of red blood cells, and sickle cell anaemia. While the cause of anaemia is imperative in treating the condition, time is also of the essence for treatment to succeed.Read Full Story PoultryDairy ProductsMalariaPregnant WomenAdolescenceAnemiaPregnancyIDAAlive And ThriveIANSIFACOVIDWIFSDepartment Of PediatricsAIIMSPraveen KumarKapil Yadav

PUNE, India — “We have seen many deaths in the past months, and so I decided to take Covaxin, and encourage others to come forward and take the Covid-19 vaccination,” said Nandu Krushnarao Satpute, a 35-year-old medicinal practitioner at Aundh Government Hospital in India’s western city of Pune. “I am...Read Full StoryNew DelhiPublic HealthWest BengalFirst ShotAIIMSDelhi Nurses ' FederationGB Pant HospitalCovishieldThe University Of OxfordBritishSwedishAstraZenecaSerum Institute Of IndiaSSKM HospitalZenger NewsNarendra ModiManish KumarRandeep GuleriaHarsha VardhanAdar Poonawalla

The Phase-III human trials of indigenous COVID-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday. M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as part of the clinical trials. Bharat Biotech announced the commencement of Phase-III trials of Covaxin on November 16. The Phase-III trials will involve 26,000 volunteers across India, conducted in partnership with ICMR.Read Full Story Human TrialsCovid-19 DiseasePublic HealthVaccineCoronavirus Disease 2019CovaxinClinical ResearchAIIMSNeurosciences CentreICMRBharat Biotech 'sVeroParticipating VolunteersThe Weather Company 'sIBM